Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Christopher F Wong"'
Publikováno v:
Ding, W Y, Gupta, D, Wong, C F & Lip, G Y H 2021, ' Pathophysiology of Atrial Fibrillation and Chronic Kidney Disease ', Cardiovascular Research, vol. 117, no. 4, cvaa258, pp. 1046–1059 . https://doi.org/10.1093/cvr/cvaa258
Atrial fibrillation (AF) and chronic kidney disease (CKD) are closely related conditions with shared risk factors. The growing prevalence of both AF and CKD indicates that more patients will suffer from concurrent conditions. There are various comple
Publikováno v:
Ding, W Y, Gupta, D, Wong, C F & Lip, G Y H 2021, ' Atrial fibrillation in the presence of chronic kidney disease : To ablation or not to ablate ', International Journal of Clinical Practice, vol. 75, no. 11, e14723 . https://doi.org/10.1111/ijcp.14723
Autor:
Archana Rao, Christopher F Wong, Asangaedem Akpan, Alice Foster, Matthew Kahn, Hani Essa, Justine Hadcroft, emeka oguguo, H Douglas, Lauren Walker, Daniel J. Cuthbertson, Julie Bellieu, Rajiv Sankaranarayanan
Publikováno v:
European Heart Journal. 42
Heart Failure is frequently associated with several comorbidities such as ischaemic heard disease, diabetes mellitus, chronic obstructive pulmonary disease, chronic kidney disease and frailty. This level of complexity is best dealt with by a multispe
Autor:
Agnieszka Kotalczyk, Christopher F Wong, Dhiraj Gupta, Anirudh Rao, Wern Yew Ding, Gregory Y.H. Lip
Publikováno v:
Kotalczyk, A, Ding, W Y, Wong, C F, Rao, A, Gupta, D & Lip, G Y H 2021, ' Atrial Fibrillation in Patients with Chronic Kidney Disease ', Cardiology Clinics, vol. 39, no. 3, pp. 435-446 . https://doi.org/10.1016/j.ccl.2021.04.005
There is a bidirectional relationship between atrial fibrillation (AF) and chronic kidney disease (CKD), with multiple shared risk factors. This article discusses an integrated care approach toward the management of patients with AF, including those
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af69b1d26c6685aa2e01e973020a7d9e
https://vbn.aau.dk/da/publications/dbeb7032-a5b9-42c0-8ab9-6f68b6f21598
https://vbn.aau.dk/da/publications/dbeb7032-a5b9-42c0-8ab9-6f68b6f21598
Autor:
Christopher F Wong, Archana Rao, Matthew Kahn, Rajiv Sankaranarayanan, Asangaedem Akpan, Julie Bellieu, emeka oguguo, Alice Foster, H Douglas, Lauren Walker, Daniel J. Cuthbertson, Hani Essa, Justine Hadcroft
Publikováno v:
Heart failure.
Background/Introduction Heart Failure is frequently associated with several comorbidities such as ischaemic heard disease, diabetes mellitus, chronic obstructive pulmonary disease, chronic kidney disease and frailty. This level of complexity is best
Autor:
Pankaj Lal, Evdokia Dardamissis, K. Abraham Abraham, Merav Kliner, Rachel Sen, Christopher F. Wong, Ken J. Mutton, Bhavna Pandya
Publikováno v:
Clinical Kidney Journal
Background. Transmission of hepatitis B virus (HBV) is rare within healthcare settings in developed countries. The aim of the article is to outline the process of identification and management of transmission of acute hepatitis B in a renal inpatient
Autor:
L Tennent, A Sharma, Thangavelu Chandrasekar, P Chamberlain, Christopher F. Wong, K A Abraham
Publikováno v:
QJM : monthly journal of the Association of Physicians. 110(10)
Background Acute kidney injury (AKI) is in the main managed by non-nephrologists, many who feel challenged by or lack awareness of the complexity that the renal element adds to their patients' care. National reports have raised major concerns about t
Autor:
Christopher F. Wong
Publikováno v:
JCR: Journal of Clinical Rheumatology. 14:61-64
Autor:
Christopher F. Wong, Muhammad S. Ahmed
Publikováno v:
Nephrology Dialysis Transplantation. 23:11-17
Nephrotic syndrome (NS) remains a therapeutic challenge to nephrologists, despite trials of different ranges of therapeutic regimens. Treatment of NS secondary to either primary glomerulonephritis (GN) or recurrence in renal transplantation remains c
Autor:
Christopher F. Wong
Publikováno v:
Nephrology Dialysis Transplantation. 22:32-36
Antineutrophil cytoplasmic antibody (ANCA)associated vasculitis (AAV) is recognized as a chronic, relapsing and potentially fatal disease. Cyclophosphamide and steroids remain the mainstay of treatment of AAV [1]. Unfortunately, in up to 10% of patie